ESBRIET
PIRFENIDONE
- Strength
- 267 mg/1
- Form
- Tablet, Coated
- Class
- Pyridone
Genentech, Inc.
Pirfenidone
Listed by Amneal Pharmaceuticals NY LLC
- Strength
- 267 mg/1
- Form
- Capsule
- Route
- Oral
- Class
- Pyridone
What it contains
- Pirfenidone 267 mg/1
FDA record
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Pyridone |
| Approval route | ANDA — approved generic |
| NDC code | 69238-1642 |
| FDA application | ANDA212569 |
| RxNorm concept | 1592279 |
| Package sizes listed | 1 |
| Marketed since | January 2022 |
Other products containing Pirfenidone
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ESBRIET
PIRFENIDONE
- Strength
- 267 mg/1
- Form
- Tablet, Coated
- Class
- Pyridone
Legacy Pharma USA Inc.
ESBRIET
PIRFENIDONE
- Strength
- 801 mg/1
- Form
- Tablet, Coated
- Class
- Pyridone
Legacy Pharma USA Inc.
ESBRIET
PIRFENIDONE
- Strength
- 801 mg/1
- Form
- Tablet, Coated
- Class
- Pyridone
Genentech, Inc.
Pirfenidone
- Strength
- 534 mg/1
- Form
- Tablet, Film Coated
- Class
- Pyridone
Laurus Labs Limited
Pirfenidone
- Strength
- 267 mg/1
- Form
- Tablet, Coated
- Class
- Pyridone
Alembic Pharmaceuticals Limited
Pirfenidone
- Strength
- 267 mg/1
- Form
- Tablet, Film Coated
- Class
- Pyridone
Amneal Pharmaceuticals NY LLC
PIRFENIDONE
- Strength
- 267 mg/1
- Form
- Tablet, Film Coated
- Class
- Pyridone
Accord Healthcare Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.